[1] |
MCINNES I B, SCHETT G. Pathogenetic insights from the treatment of rheumatoid arthritis[J]. Lancet, 2017, 389(10086):2328-2337.
DOI
PMID
|
[2] |
DEANE K D, HOLERS V M. Rheumatoid arthritis pathogenesis,prediction,and prevention:an emerging paradigm shift[J]. Arthritis Rheumatol, 2021, 73(2):181-193.
DOI
URL
|
[3] |
SMOLEN J S, ALETAHA D, MCINNES I B. Rheumatoid arthritis[J]. Lancet, 2016, 388(10055):2023-2038.
DOI
PMID
|
[4] |
CUSH J J. Rheumatoid arthritis:early diagnosis and treatment[J]. Rheum Dis Clin North Am, 2022, 48(2):537-547.
DOI
URL
|
[5] |
WITHROW J, MURPHY C, LIU Y, et al. Extracellular vesicles in the pathogenesis of rheumatoid arthritis and osteoarthritis[J]. Arthritis Res Ther, 2016, 18(1):286.
PMID
|
[6] |
LITTLEJOHN E A, MONRAD S U. Early diagnosis and treatment of rheumatoid arthritis[J]. Prim Care, 2018, 45(2):237-255.
DOI
PMID
|
[7] |
HUBER R, HUMMERT C, GAUSMANN U, et al. Identification of intra-group,inter-individual,and gene-specific variances in mRNA expression profiles in the rheumatoid arthritis synovial membrane[J]. Arthritis Res Ther, 2008, 10(4):R98.
DOI
URL
|
[8] |
WOETZEL D, HUBER R, KUPFER P, et al. Identification of rheumatoid arthritis and osteoarthritis patients by transcriptome-based rule set generation[J]. Arthritis Res Ther, 2014, 16(2):R84.
DOI
URL
|
[9] |
BASU P, CAI T T, DAS K, et al. Weighted false discovery rate control in large-scale multiple testing[J]. J Am Stat Assoc, 2018, 113(523):1172-1183.
DOI
PMID
|
[10] |
CAGLAR H O, DUZGUN Z. Identification of upregulated genes in glioblastoma and glioblastoma cancer stem cells using bioinformatics analysis[J]. Gene, 2023, 848:146895.
DOI
URL
|
[11] |
CHENG Q, CHEN X, WU H, et al. Three hematologic/immune system-specific expressed genes are considered as the potential biomarkers for the diagnosis of early rheumatoid arthritis through bioinformatics analysis[J]. J Transl Med, 2021, 19(1):18.
DOI
PMID
|
[12] |
中华医学会风湿病学分会. 2018中国类风湿关节炎诊疗指南[J]. 中华内科杂志, 2018, 57(4):242-251.
|
[13] |
中华中医药学会风湿病分会. 骨关节炎病证结合诊疗指南[J]. 中华中医药杂志, 2021, 36(2):929-932.
|
[14] |
VAN RIEL P L, RENSKERS L. The disease activity score(DAS) and the disease activity score using 28 joint counts(DAS28) in the management of rheumatoid arthritis[J]. Clin Exp Rheumatol, 2016, 34(5 Suppl 101):S40-S44.
|
[15] |
FINCKH A, GILBERT B, HODKINSON B, et al. Global epidemiology of rheumatoid arthritis[J]. Nat Rev Rheumatol, 2022, 18(10):591-602.
DOI
PMID
|
[16] |
SHAH P, SIDDIQUE A, THAKKAR A, et al. An update on novel therapeutic intervention in rheumatoid arthritis[J]. Int Immunopharmacol, 2022, 109:108794.
DOI
URL
|
[17] |
WEYAND C M, GORONZY J J. The immunology of rheumatoid arthritis[J]. Nat Immunol, 2021, 22(1):10-18.
DOI
PMID
|
[18] |
YU X, SONG Z, RAO L, et al. Synergistic induction of CCL5,CXCL9 and CXCL10 by IFN-gamma and NLRs ligands on human fibroblast-like synoviocytes-A potential immunopathological mechanism for joint inflammation in rheumatoid arthritis[J]. Int Immunopharmacol, 2020, 82:106356.
DOI
URL
|
[19] |
MENG Q, QIU B. Exosomal microRNA-320a derived from mesenchymal stem cells regulates rheumatoid arthritis fibroblast-like synoviocyte activation by suppressing CXCL9 expression[J]. Front Physiol, 2020, 11:441.
DOI
PMID
|
[20] |
KOTRYCH D, DZIEDZIEJKO V, SAFRANOW K, et al. Lack of association between CXCL9 and CXCL10 gene polymorphisms and the outcome of rheumatoid arthritis treatment with methotrexate[J]. Eur Rev Med Pharmacol Sci, 2015, 19(16):3037-3040.
|
[21] |
KOTRYCH D, DZIEDZIEJKO V, SAFRANOW K, et al. CXCL9 and CXCL10 gene polymorphisms in patients with rheumatoid arthritis[J]. Rheumatol Int, 2015, 35(8):1319-1323.
DOI
URL
|
[22] |
BAKHEET S A, ANSARI M A, NADEEM A, et al. CXCR3 antagonist AMG487 suppresses rheumatoid arthritis pathogenesis and progression by shifting the Th17/Treg cell balance[J]. Cell Signal, 2019, 64:109395.
DOI
URL
|
[23] |
LARAGIONE T, BRENNER M, SHERRY B, et al. CXCL10 and its receptor CXCR3 regulate synovial fibroblast invasion in rheumatoid arthritis[J]. Arthritis Rheum, 2011, 63(11):3274-3283.
DOI
URL
|
[24] |
HONKALA A T, TAILOR D, MALHOTRA S V. Guanylate-binding protein 1:an emerging target in inflammation and cancer[J]. Front Immunol, 2020, 10:3139.
DOI
URL
|
[25] |
HAQUE M, SINGH A K, OUSEPH M M, et al. Regulation of synovial inflammation and tissue destruction by guanylate binding protein 5 in synovial fibroblasts from patients with rheumatoid arthritis and rats with adjuvant-induced arthritis[J]. Arthritis Rheumatol, 2021, 73(6):943-954.
DOI
URL
|